Moderna and Merck Cancer Combo Shows Strong 5-Year Trial Results

Event Summary

On May 21, mid-stage trial data revealed that the combination therapy between Moderna and Merck reduced the risk of cancer spreading by 59% after five years of follow-up. These strong results offer new hope in cancer treatment.